Article in Journal

Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients

Crudele L, De Matteis C, Novielli F, Petruzzelli S, Di Buduo E, Graziano G, Cariello M, Piccinin E, Gadaleta RM, Moschetta A

Intern Emerg Med., 2024, 19(5), 1267-1277

OwnerUniversità degli Studi di Bari Aldo Moro
OPEN ACCESS

April 25, 2024

Related to
Spoke 04

  1. Home

     / 

  2. Research outputs

     / 

  3. Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retr...

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of increased adiposopathy, whose pathogenetic features have been proposed as tumourigenic triggers for colorectal cancer (CRC). We aim to identify specific metabolic signatures involved in CRC development that may be used as non-invasive biomarkers, paving the way for specific and personalized strategies of CRC prevention and early detection.

This research output is related to

Spoke 04

Food quality and nutrition

To push towards sustainable and tailored food and nutrition
Lead organisationUniMi
Spoke leaderPatrizia Riso
Research projectOMI_MET

Nutri-omics signatures in mets patients

Managed by

UniBa

Principal investigators

Antonio Moschetta,Marialisa Clodoveo,Maria Calasso,Gaetano Villani

Referred to

Spoke 04